The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 8 of the 48 sources its claims cite were checked for support.
MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial
Open accessAbstract
Objective: Health-related quality of life (HRQOL) is often much reduced among individuals with multiple sclerosis (MS), and incidences of depression, fatigue, and anxiety are high. We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.Methods: A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74). MBI consisted of a structured 8-week program of mindfulness training. Assessments were made at baseline, postintervention, and 6 months follow-up. Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue. Anxiety, personal goal attainment, and adherence to homework were secondary outcomes.Results: Attrition was low in the intervention group (5%) and attendance rate high (92%). Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p < 0.002); effect sizes, 0.4-0.9 posttreatment and 0.3-0.5 at follow-up. When analyses were repeated among subgroups with clinically relevant levels of preintervention depression, fatigue, or anxiety, postintervention and follow-up effects remained significant and effect sizes were larger than for the total sample.Conclusions: In addition to evidence of improved HRQOL and well-being, these findings demonstrate broad feasibility and acceptance of, as well as satisfaction and adherence with, a program of mindfulness training for patients with MS. The results may also have treatment implications for other chronic disorders that diminish HRQOL.Classification Of Evidence: This trial provides Class III evidence that MBI compared with UC improved HRQOL, fatigue, and depression up to 6 months postintervention.
Overview
CoChat Summary
TL;DR
In a randomized trial of 150 adults with relapsing-remitting or secondary progressive MS, an 8-week mindfulness-based intervention improved nonphysical health-related quality of life, depression, fatigue, and anxiety compared with usual care at postintervention and 6-month follow-up. Effects were significant overall and larger in subgroups with clinically relevant preintervention depression, fatigue, or anxiety, though some HRQOL and depression gains attenuated by follow-up.
Key findings
- MBI (n = 76) vs UC (n = 74) improved nonphysical primary outcomes at postintervention and follow-up (p < 0.002); effect sizes were 0.4–0.9 posttreatment and 0.3–0.5 at follow-up. Number needed to treat ranged from 2.5 to 6.4 postintervention and 5.8 to 8.2 at 6-month follow-up.
- In subgroups with clinically relevant preintervention depression, fatigue, or anxiety, postintervention and follow-up effects remained significant and effect sizes were larger; NNTs ranged from 1.6 to 3.3 postintervention and 3.8 to 5.6 at follow-up. Clinically significant levels of depression, fatigue, or anxiety were found in 40%–44% of patients, and 62% showed evidence of at least one.
- Anxiety improved similarly to primary outcomes. MBI participants practiced on average 5.11 times/week (SD 2.24) and completed 76% of assigned homework (SD 13.80); practice correlated with improvements in PQOLC, depression, and fatigue (r = 0.25–0.31; p < 0.04). Mean goal attainment was 1.78 (SD 1.2).
- No group differences were found on HAQUAMS lower and upper limb mobility subscales (p > 0.60), and there were no main or interaction effects for gender, disease-modifying drugs, or EDSS level. Attrition was 5% in MBI and attendance was 92%.
Methods
- Randomized controlled trial conducted February 2007 to March 2009; 164 patients self-referred, 150 were randomized after exclusions/declines. Inclusion criteria included relapsing-remitting or secondary progressive MS and EDSS ≤6.
- MBI consisted of a structured 8-week program: weekly 2.5-hour classes, one 7-hour Saturday session at week 6, and approximately 40 minutes/day of homework, compared with usual care. Assessments occurred at baseline, postintervention, and 6-month follow-up.
- Primary outcomes were disease-specific and disease-aspecific HRQOL (HAQUAMS, PQOLC), depression (CES-D), and fatigue (MFIS); secondary outcomes included anxiety (STAI), goal attainment, and homework adherence. Intention-to-treat analyses used multiple regression imputation and repeated-measures multivariate ANCOVA with planned contrasts, effect sizes, and NNT.
Limitations
- The paper states that UC was not an active control, so the specificity of MBI was not evaluated; effects may have been influenced by nonspecific factors such as social support, motivation, or placebo. Outcomes were patient-reported only and susceptible to response biases, and mechanisms of benefit remain unclear.
- The paper states that benefits in disease-aspecific HRQOL and depressive symptoms were reduced from postintervention to 6-month follow-up, suggesting the 2-month intervention may require booster sessions. MBI did not appear to benefit physical functioning.
- Evident from the text: the sample was predominantly female (119:31), self-referred, and drawn from a single Swiss center, limiting generalizability; no comparisons were made between refusers/dropouts and completers because of small numbers.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 0 Not valid · 10 Not checked · 65 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“many disease-modifying drug regimens appear to produce modest or no improvements in HRQOL7,11–14 or even negative changes.15”
What the sources say
- Not checked yetcites [7] Haupts M, Elias G, Hardt C, et al. [Quality of life in patients with remitting-relapsing multiple sclerosis in Germany.] Nervenarzt 2003;74:144–150. [DOI] [PubMed] [Google Scholar]
- Not checked — no full text of the sourcecites [11] Putzki N, Fischer J, Gottwald K, et al. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol 2009;16:713–720. [DOI] [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [12] Vermersch P, de Seze J, Delisse B, Lemaire S, Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-beta1a (Avonex) treatment. Mult Scler 2002;8:377–381. [DOI] [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [13] Zivadinov R, Zorzon M, Tommasi MA, et al. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol Sci 2003;216:113–118. [DOI] [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [14] Rudick RA, Miller D, Hass S, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol 2007;62:335–346. [DOI] [PubMed] [Google Scholar] source
- Supportedcites [15] Simone IL, Ceccarelli A, Tortorella C, et al. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes 2006;4:96. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Citation 15 is attached to “or even negative changes.” The Results report significantly worsened mental health scores after two years in the IFN-β-treated group, and the Conclusion states that IFN-β treatment had a negative impact on quality of life in patients with MS. (LLM, conf=0.93)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Controlled trials of behavioral interventions among patients with MS have focused upon treatment of depression, fatigue, or anxiety in patients selected for high symptom severity.16–18”
What the sources say
- Not checked — no full text of the sourcecites [16] Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001;69:942–949. [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [17] Crawford JD, McIvor GP. Group psychotherapy: benefits in multiple sclerosis. Arch Phys Med Rehabil 1985;66:810–813. [PubMed] [Google Scholar] doi:10.5555/uri:pii:0003999385902333
- Partly supportedcites [18] Tesar N, Baumhackl U, Kopp M, Gunther V. Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurol Scand 2003;107:394–399. [DOI] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The study describes a controlled psychological intervention for patients with MS and assesses depression and anxiety (opening summary; page not supplied). But the Subjects section says participants were recruited from an outpatient clinic based on MS diagnosis and other eligibility criteria, not selected for high symptom severity; it also excludes patients with psychiatric illnesses and describes many depressive symptoms as mild. The program additionally targeted coping and body image, so the cited study does not support the claim's characterization of its focus or patient selection in full. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HRQOL psychosocial impairment shows great variation among patients with MS and is, to an important degree, independent of extent of disease.6–10”
What the sources say
- Not checked — no full text of the sourcecites [6] Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 2001;23:516–521. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [7] Haupts M, Elias G, Hardt C, et al. [Quality of life in patients with remitting-relapsing multiple sclerosis in Germany.] Nervenarzt 2003;74:144–150. [DOI] [PubMed] [Google Scholar]
- Partly supportedcites [8] Murphy N, Confavreux C, Haas J, et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom: Cost of Multiple Sclerosis Study Group. J Neurol Neurosurg Psychiatry 1998;65:460–466. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The MAIN SCALES and Discussion sections (page unavailable) report that psychological function was lower in patients with MS than in controls but did not correlate with disease severity. The claim is broader than that finding: social role function, another psychosocial measure, was associated with severity in some countries, and the paper does not establish that psychosocial impairment generally varies greatly between patients. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [9] Koch M, Uyttenboogaart M, van Harten A, Heerings M, De Keyser J. Fatigue, depression and progression in multiple sclerosis. Mult Scler 2008;14:815–822. [DOI] [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [10] Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Mult Scler 2009;15:752–758. [DOI] [PubMed] [Google Scholar] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“HRQOL psychosocial impairment shows great variation among patients with MS and is, to an important degree, independent of extent of disease.6–10”
What the sources say
- Not checked — no full text of the sourcecites [6] Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 2001;23:516–521. [DOI] [PubMed] [Google Scholar] source
- Not checked yetcites [7] Haupts M, Elias G, Hardt C, et al. [Quality of life in patients with remitting-relapsing multiple sclerosis in Germany.] Nervenarzt 2003;74:144–150. [DOI] [PubMed] [Google Scholar]
- Supportedcites [8] Murphy N, Confavreux C, Haas J, et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom: Cost of Multiple Sclerosis Study Group. J Neurol Neurosurg Psychiatry 1998;65:460–466. [DOI] [PMC free article] [PubMed] [Google Scholar] source
Table 3 reports substantial variation in psychological-function scores among patients with MS (standard deviations of 17.5–22.1 points) and in social-role scores (15.2–16.5 points). The Main Scales section identifies these as distinct quality-of-life domains, supporting the paraphrase about variation in psychosocial impairment. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [9] Koch M, Uyttenboogaart M, van Harten A, Heerings M, De Keyser J. Fatigue, depression and progression in multiple sclerosis. Mult Scler 2008;14:815–822. [DOI] [PubMed] [Google Scholar] source
- Not checked — no full text of the sourcecites [10] Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Mult Scler 2009;15:752–758. [DOI] [PubMed] [Google Scholar] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At postintervention, all subscales of the PQOLC showed greater improvements among MBI participants in contrast to the UC group (p < 0.001)”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
30 more claims
Create a free account to see all 83 claims and to verify the 4 references still open.
- Probably not a substantial claim. 31
- It may state two separate claims as one. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“satisfaction with life, and quality of life (Grossman et al., 2010; Koszycki et al., 2007; Nyklíček, & Kuijpers,2008; Shapiro et al., 2005)”
From Effects of mindfulness on psychological health: A review of empirical studies (2011) · cites this paper as Grossman et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people with Multiple Sclerosis (MS), MBIs again do not directly improve disease symptoms but do improve QoL alongside sleep problems, fatigue, and illness perception [38,39].”
From Mindfulness and physical disease: a concise review (2019) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This shift in perspective can reduce catastrophizing and emotional reactivity, which are known to worsen pain experiences and diminish quality of life.”
From The effectiveness of mindfulness as a complementary therapy in headache patients: a preliminary interventional study (2025) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mindfulness allows patients to relate to their physical and psychological symptoms in a different, more skillful way, with a positive effect on developing a realistic sense of control and appropriate strategies in becoming adaptive (Kabat-Zinn et al., 1986; Grossman et al., 2010).”
From The Development of Mindful-Based Dance Movement Therapy Intervention for Chronic Pain: A Pilot Study With Chronic Headache Patients (2021) · cites this paper as Grossman et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Statistical power calculation was based on previous studies [28, 48]: assuming power =0.80 and 0.05 significance, a minimal sample size of 44 patients/group will be required, based on an effect size of 0.54.”
From The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial. (2016) · cites this paper as [28]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS
“Because we did not hypothesize that MBI would influence disease, we employed the sum of the other subscales as the measure of HRQOL, and separately report findings for the limb mobility subscales.”
§ METHODS
“HRQOL measures were derived by averaging PQOLC and HAQUAMS subscale scores at each timepoint.”
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
(1970) · Cited by 24,983
(2008) · Medical Entomology and Zoology · Cited by 7,477
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Mindfulness-based stress reduction and health benefits
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00573-7 · Cited by 3,958
Self-citationMindfulness-based stress reduction and health benefits: A meta-analysis
Grossman, P., Niemann, L., Schmidt, S., & Walach, H. (2003) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2003.tb04008.x · Cited by 1,394
Self-citationDepression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Flachenecker, P., Kümpfel, T., Kallmann, B., Gottschalk, M., Grauer, O., Rieckmann, P., Trenkwalder, C., & Toyka, K. V. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms839oa · Cited by 634
Grossman, P., Tiefenthaler-Gilmer, U., Raysz, A., & Kesper, U. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000101501 · Cited by 505
Self-citation
Cited by
Effects of mindfulness on psychological health: A review of empirical studies
Keng, S.-L., Smoski, M. J., & Robins, C. J. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.04.006 · Cited by 2,687
“…WL (16) MBSRNWL: reduced activation in medial and lateral brain regions, reduced deactivation in insula and other visceral and somasensory areas Grossman et al., 2010 150 Patients with multiple sclerosis 47 21 8 2.5-h sessions, 1 7-h session UC (74) MBSRNUC: increases in health-related quality…”
BackgroundInfluentialFatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy
Kluger, B. M., Krupp, L. B., & Enoka, R. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f07be · Cited by 1,036
Loving-Kindness and Compassion Meditation: Potential for Psychological Interventions
Hofmann, S. G., Grossman, P., & Hinton, D. E. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.07.003 · Cited by 960
“…moment-to-moment experience, (d) continuity of a precise, dispassionate, non-evaluative, and sustained moment-to-moment awareness of immediate experience, and (e) an attitude of openness, acceptance, kindness, curiosity and patience (see Grossman et al., 2004, 2010; Grossman & Van Dam, in press).”
Self-citationFjorback, L. O., Arendt, M., Ørnbøl, E., Fink, P., & Walach, H. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01704.x · Cited by 803
“In clinical populations with physical illness, MBSR complements medical disease management by relieving psychological distress and strengthening wellbeing (19, 28, 29, 32, 35, 36, 47).”
BackgroundResultInfluentialSome Reflections on the Origins of MBSR, Skillful Means, and the Trouble with Maps
Kabat-Zinn, J. (2011) · Contemporary Buddhism · doi:10.1080/14639947.2011.564844 · Cited by 800
“Now there are growing movements to bring mindfulness into K-12 education (Burnett and Cullen 2010; Grossman et al. 2010; Kaiser-Greenland 2010), into the military (Jha et al. 2010; Stanley and Jha 2009; Stanley et al. 2011), and into prisons (Menahemi and Ariel 1997, Phillips 2008; Samuelson et al.…”
Background
Metadata
- Authors
- Grossman, P., Kappos, L., Gensicke, H., D'Souza, M., Mohr, D. C., Penner, I. K., & Steiner, C.
- Affiliations
- Northwestern University (US)
- Venue
- Neurology
- Published
- 2010-09-28
- Volume
- 75
- Issue
- 13
- Pages
- 1141-1149
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3463050
- OpenAlex
- W2157656577
- Cited by
- 419
- References
- 40
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 14 · 2023: 21 · 2022: 21 · 2021: 26 · 2020: 19 · 2019: 48 · 2018: 34 · 2017: 34 · 2016: 31 · 2015: 23 · 2014: 37 · 2013: 25 · 2012: 28
- FWCI
- 27.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hd043323-05)
- National Institute of Mental Health (R34MH078922, R01MH059708)
- National Center for Research Resources (UL1RR025741)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD043323, RL1HD058295)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, mindfulness-based interventions, mindfulness training, health-related quality of life, depression, fatigue, anxiety, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, medication adherence, feasibility and acceptability
- MeSH terms
- Adult, Analysis of Variance, Depression, Disability Evaluation, Double-Blind Method, Fatigue, Female, Follow-Up Studies, Humans, Male, Middle Aged, Multiple Sclerosis, Neuropsychological Tests, Quality of Life, Treatment Outcome, Mind-Body Therapies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-27, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-27 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. https://app.cochat.ai/papers/10.1212/wnl.0b013e3181f4d80d
- The paper
- Grossman, P., Kappos, L., Gensicke, H., D'Souza, M., Mohr, D. C., Penner, I. K., & Steiner, C. (2010). MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology. https://doi.org/10.1212/wnl.0b013e3181f4d80d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.